Neoadjuvant therapy affects tumor growth markers in early stage non-small-cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neoadjuvant therapy affects tumor growth markers in early stage non-small-cell lung cancer

Published:2009-12 Issue:S4 Volume:14 Page:
ISSN:2047-783X
Container-title:European Journal of Medical Research
language:en
Short-container-title:Eur J Med Res

Author:

Chorostowska-Wynimko J,Zaleska J,Chabowski M,Szpechcinski A,Zych J,Rudzinski P,Langfort R,Orlowski T,Roszkowski-Sliz K

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/2047-783X-14-S4-42.pdf

Reference10 articles.

1. Scagliotti G: Multimodality approach to early-stage non-small cell lung cancer. Lung Cancer 2007,57(Suppl 2):S6–11.

2. Depierre A, Milleron B, Moro-Sibilot D, Chevret S, Quoix E, Lebeau B, Braun D, Breton JL, Lemarie E, Gouva S, Paillot N, Brechot JM, Janicot H, Lebas FX, Terrioux P, Clavier J, Foucher P, Monchatre M, Coetmeur D, Level MC, Leclerc P, Blanchon F, Rodier JM, Thiberville L, Villeneuve A, Westeel V, Chastang C: Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol 2002,20(1):247–253. 10.1200/JCO.20.1.247

3. Brahmer JR, Ettinger DS: Non-small cell lung cancer: adjuvant and neo-adjuvant chemotherapy. Respirology 2007,12(3):320–325. 10.1111/j.1440-1843.2007.01081.x

4. Teicher BA: Malignant cells, directors of the malignant process: role of transforming growth factor-beta. Cancer Metastasis Rev 2001,20(1–2):133–143.

5. Filyak Y, Filyak O, Souchelnytskyi S, Stoika R: Doxorubicin inhibits TGF-beta signaling in human lung carcinoma A549 cells. Eur J Pharmacol 2008,590(1–3):67–73. 10.1016/j.ejphar.2008.05.030

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. sVEGF R1 and Tie-2 Levels During Chemotherapy of Lung Cancer Patients;Advances in Experimental Medicine and Biology;2012-06-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3